As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global market for anaemia drugs is being driven by the growing prevalence of CKD anaemia segment over the forecast period as chronic kidney diseases are becoming prevalent across many regions. Further, the exponential growth of e-commerce segment as a distribution channel, is expected to foster the market growth of anaemia drugs due to user convenience. The market is dependent on many factors like the rising geriatric population, rapid R&D activities, and better healthcare infrastructure that are predicted to fuel the overall growth of the market.
The market is further driven by the ongoing developments by the key industry players like Pfizer Inc. and Amgen Inc. (NASDAQ: AMGN). On 15 May 2018, Pfizer Inc. announced that the US Food and Drug Administration (FDA) has given approval to RETACRIT® (epoetin alfa-epbx), which is a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the mentioned product. RETACRIT® is claimed to offer patients and their physicians more access to high-quality, lower-cost alternative treatment option for anaemia and a decrease in allogeneic RBC transfusions in certain patients. Such developments in the field of anaemia drugs to address the advancing needs of patients and the vast healthcare community are predicted to aid the market growth over the forecast period.
Market Analysis by Anaemia Type, Drugs, Distribution Channel, and Region:
Key Findings of the Report:
Key Offerings of the Report:
Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., Takeda Pharmaceutical Company Limited, among others are the key players in the global anaemia drugs market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.